J Korean Acad Periodontol.  2009 Aug;39(Suppl):223-230.

Bone regeneration capacity of two different macroporous biphasic calcium materials in rabbit calvarial defect

Affiliations
  • 1Department of Periodontology, Research Institute for Periodontal Regeneration, College of Dentistry, Yonsei University, Korea. shchoi726@yuhs.ac
  • 2Department of Dentistry, College of Medicine, Kwandong University, Myongji Hospital, Korea.

Abstract

ABSTRACT PURPOSE: Synthetic bone products such as biphasic calcium phosphate (BCP) are mixtures of hydroxyapatite (HA) and a- tricalcium phosphate (a- TCP). In periodontal therapies and implant treatments, BCP provides to be a good bone reconstructive material since it has a similar chemical composition to biological bone apatites. The purpose of this study was to compare bone regeneration capacity of two commercially available BCP.
METHODS
Calvarial defects were prepared in sixteen 9-20 months old New Zealand White male rabbits. BCP with HA and a- TCP (70:30) and BCP with Silicon-substituted hydroxyapatite (Si-HA) and a-TCP (60:40) particles were filled in each defect. Control defects were filled with only blood clots. Animals were sacrificed at 4 and 8 week postoperatively. Histomorphometric analysis was performed.
RESULTS
BCP with HAand a- TCP 8 weeks group and BCP with Si-HA and a- TCP 4 and 8 weeks groups showed statistically significant in crease (P<0.05) in augmented area than control group. Newly formed bone area after 4 and 8 weeks was similar among all the groups. Residual materials were slightly more evident in BCP with HA and a- TCP 8 weeks group.
CONCLUSIONS
Based on histological results, BCP with HA and a- TCP and BCP with Si-HA and a- TCP appears to demonstrate acceptable space maintaining capacity and elicit significant new bone formation when compared to natural bone healing in 4 and 8 week periods.

Keyword

bone substitutes; hydroxyapatite wound healing

MeSH Terms

Animals
Apatites
Bone Regeneration
Bone Substitutes
Calcium
Calcium Phosphates
Durapatite
Humans
Hydroxyapatites
Male
New Zealand
Osteogenesis
Rabbits
Apatites
Bone Substitutes
Calcium
Calcium Phosphates
Durapatite
Hydroxyapatites

Figure

  • Figure 1 Schematicdrawing of designated material filled in defects. Dotted line represents sagittal suture of cranium; A: Control, B: Bonemedik-DM®, C: Osteon®.

  • Figure 2 Light micrographs of control group at 4 weeks postoperatively. Thick fibrous tissue is covering the defect ×6 (A), ×200 (B).

  • Figure 3 Light micrographs of control group at 8 weeks postoperatively. Mature bone tissue is observed among connective tissue ×16 (A), ×200 (B).

  • Figure 4 Light micrographs of Osteon group at 4 weeks postoperatively. Relatively large particle of residual materials are surrounded obsteoblasts and newly formed bone ×16 (A), ×200 (B).

  • Figure 5 Light micrographs of Osteon group at 8 weeks postoperatively. Relatively small particles are scattered and newly formed bone are surrounding ×16 (A), ×200 (B).

  • Figure 6 Light micrographs of Bonemedik-DM at 4 weeks postoperatively. Active resorption process is observed ×16 (A), ×200 (B).

  • Figure 7 Light micrographs of Bonemedik-DM at 8 weeks postoperatively. Mature bone tissue is apposed interspace of residual materials ×16 (A), ×200 (B).


Reference

1. Barboza EP. Clinical and histologic evaluation of the demineralized freeze-dried bone membrane used for ridge augmentation. Int J Periodontics Restorative Dent. 1999. 19:601–607.
2. Daculsi G, Laboux O, Malard O, Weiss P. Current state of the art of biphasic calcium phosphate bioceramics. J Mater Sci Mater Med. 2003. 14:195–200.
3. Daculsi G, Passuti N, Martin S, et al. Macroporous calcium phosphate ceramic for long bone surgery in humans and dogs. Clinical and histological study. J Biomed Mater Res. 1990. 24:379–396.
Article
4. LeGeros RZ, Parsons JR, Daculsi G, et al. Significance of the porosity and physical chemistry of calcium phosphate ceramics. Biodegradation-bioresorption. Ann N Y Acad Sci. 1988. 523:268–271.
Article
5. Levin MP, Getter L, Adrian J, Cutright DE. Healing of periodontal defects with ceramic implants. J Clin Periodontol. 1974. 1:197–205.
Article
6. Levin MP, Getter L, Cutright DE, Bhaskar SN. Biodegradable ceramic in periodontal defects. Oral Surg Oral Med Oral Pathol. 1974. 38:344–351.
Article
7. Yukna RA, Cassingham RJ, Caudill RF, et al. Six month evaluation of Calcitite (hydroxyapatite ceramic) in periodontal osseous defects. Int J Periodontics Restorative Dent. 1986. 6:34–45.
8. Froum SJ, Kushner L, Scopp IW, Stahl SS. Human clinical and histologic responses to Durapatite implants in intraosseous lesions. Case reports. J Periodontol. 1982. 53:719–725.
Article
9. Moskow BS, Lubarr A. Histological assessment of human periodontal defect after durapatite ceramic implant. Report of a case. J Periodontol. 1983. 54:455–462.
Article
10. Ellinger RF, Nery EB, Lynch KL. Histological assessment of periodontal osseous defects following implantation of hydroxyapatite and biphasic calcium phosphate ceramics: a case report. Int J Periodontics Restorative Dent. 1986. 6:22–33.
11. Karabuda C, Ozdemir O, Tosun T, Anil A, Olgac V. Histological and clinical evaluation of 3 different grafting materials for sinus lifting procedure based on 8 cases. J Periodontol. 2001. 72:1436–1442.
Article
12. Jarcho M. Calcium phosphate ceramics as hard tissue prosthetics. Clin Orthop Relat Res. 1981. 00:259–278.
Article
13. Jarcho M. Biomaterial aspects of calcium phosphates. Properties and applications. Dent Clin North Am. 1986. 30:25–47.
14. Nery EB, LeGeros RZ, Lynch KL, Lee K. Tissue response to biphasic calcium phosphate ceramic with different ratios of HA/beta TCP in periodontal osseous defects. J Periodontol. 1992. 63:729–735.
Article
15. Block MS, Kent JN. A comparison of particulate and solid root forms of hydroxylapatite in dog extraction sites. J Oral Maxillofac Surg. 1986. 44:89–93.
Article
16. Lee J, Jung U, Kim C, Choi S, Cho K. Maxillary sinus augmentation using macroporous biphasic calcium phosphate (MBCP™): Three case report with histologic evaluation. J Korean Acad Periodontol. 2006. 36:567–577.
Article
17. Daculsi G, LeGeros RZ, NeryE , Lynch K, Kerebel B. Transformation of biphasic calcium phosphate ceramics in vivo: ultrastructural and physicochemical characterization. J Biomed Mater Res. 1989. 23:883–894.
Article
18. Bertoni E, Bigi A, Cojazzi G, et al. Nanocrystals of magnesium and fluoride substituted hydroxyapatite. J Inorg Biochem. 1998. 72:29–35.
Article
19. Skrtic D, Antonucci JM, Eanes ED, Brunworth RT. Silicaand zirconia-hybridized amorphous calcium phosphate: effect on transformation to hydroxyapatite. J Biomed Mater Res. 2002. 59:597–604.
Article
20. Hollinger JO, Kleinschmidt JC. The critical size defect as an experimental model to test bone repair materials. J Craniofac Surg. 1990. 1:60–68.
Article
21. Marx RE, Carlson ER, Eichstaedt RM, et al. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998. 85:638–646.
22. Sandy J, Davies M, Prime S, Farndale R. Signal pathways that transduce growth factor-stimulated mitogenesis in bone cells. Bone. 1998. 23:17–26.
Article
23. Horner A, Bord S, Kemp P, Grainger D, Compston JE. Distribution of platelet-derived growth factor (PDGF) A chain mRNA, protein, and PDGF-alpha receptor in rapidly forming human bone. Bone. 1996. 19:353–362.
Article
24. Lee YJ, Jung SW, Chae GJ, Cho KS, Kim CS. The effect of recombinant human bone morphogenetic protein-2/macroporous biphasic calcium phosphate block system on bone formation in rat calvarial defects. J Korean Acad Periodontol. 2007. 37:397–407.
Article
25. Wikesjo UM, Huang YH, Polimeni G, Qahash M. Bone morphogenetic proteins: a realistic alternative to bone grafting for alveolar reconstruction. Oral Maxillofac Surg Clin North Am. 2007. 19:535–551. vi–vii.
Article
26. Klein CP, Driessen AA, de Groot K, van den Hooff A. Biodegradation behavior of various calcium phosphate materials in bone tissue. J Biomed Mater Res. 1983. 17:769–784.
Article
27. Kwon S, Jun Y, Hong S. Synthesis and dissolution behavior of β-TCP and HA/β-TCP composite powders. J Euro Ceram Soc. 2003. 23:1039–1045.
Article
28. Gauthier O, Bouler JM, Aguado E, Pilet P, Daculsi G. Macroporous biphasic calcium phosphate ceramics: influence of macropore diameter and macroporosity percentage on bone ingrowth. Biomaterials. 1998. 19:133–139.
Article
29. LeGeros RZ. Calcium phosphate materials in restorative dentistry: a review. Adv Dent Res. 1988. 2:164–180.
Article
30. Metsger DS, Driskell TD, Paulsrud JR. Tricalcium phosphate ceramic--a resorbable bone implant: review and current status. J Am Dent Assoc. 1982. 105:1035–1038.
Article
31. Um YJ, Hong JY, Kim ST, et al. Bone formation of newly developed biphasic calcium phosphate in rabbit calvarial defect model : A pilot study. J Korean Acad Periodontol. 2008. 38:163–170.
Article
Full Text Links
  • JKAPE
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr